Ampio Pharm Stock Cash Flow From Operations
| AMPEDelisted Stock | USD 0.24 0.01 4.35% |
Ampio Pharm fundamentals help investors to digest information that contributes to Ampio Pharm's financial success or failures. It also enables traders to predict the movement of Ampio Pink Sheet. The fundamental analysis module provides a way to measure Ampio Pharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ampio Pharm pink sheet.
Ampio |
Ampio Pharm Company Cash Flow From Operations Analysis
Ampio Pharm's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Ampio Pharm Cash Flow From Operations | (8.56 M) |
Most of Ampio Pharm's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ampio Pharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Ampio Pharm has (8.56 Million) in Cash Flow From Operations. This is 101.62% lower than that of the Pharmaceuticals sector and 113.7% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 100.88% higher than that of the company.
Ampio Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ampio Pharm's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ampio Pharm could also be used in its relative valuation, which is a method of valuing Ampio Pharm by comparing valuation metrics of similar companies.Ampio Pharm is currently under evaluation in cash flow from operations category among its peers.
Ampio Fundamentals
| Return On Equity | -1.14 | ||||
| Return On Asset | -0.62 | ||||
| Current Valuation | (3.33 M) | ||||
| Shares Outstanding | 1.14 M | ||||
| Shares Owned By Insiders | 1.56 % | ||||
| Shares Owned By Institutions | 4.19 % | ||||
| Number Of Shares Shorted | 32.9 K | ||||
| Price To Earning | 28.57 X | ||||
| Price To Book | 0.21 X | ||||
| EBITDA | (8.63 M) | ||||
| Net Income | (8.63 M) | ||||
| Cash And Equivalents | 23.25 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 274 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 4.85 X | ||||
| Book Value Per Share | 4.03 X | ||||
| Cash Flow From Operations | (8.56 M) | ||||
| Short Ratio | 0.31 X | ||||
| Earnings Per Share | (10.66) X | ||||
| Target Price | 2.0 | ||||
| Beta | 1.95 | ||||
| Market Capitalization | 340.61 K | ||||
| Total Asset | 5.74 M | ||||
| Retained Earnings | (242.53 M) | ||||
| Working Capital | 3.36 M | ||||
| Current Asset | 29.23 M | ||||
| Current Liabilities | 5.52 M | ||||
| Net Asset | 5.74 M |
About Ampio Pharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ampio Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ampio Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ampio Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |